A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2002-04, Vol.51 (4), p.1083
Hauptverfasser: Etgen, Garret J, Oldham, Brian A, Johnson, William T, Broderick, Carol L, Montrose, Chahrzad R, Brozinick, Joseph T, Misener, Elizabeth A, Bean, James S, Bensch, William R, Brooks, Dawn A, Shuker, Anthony J, Rito, Christopher J, McCarthy, James R, Ardecky, Robert J, Tyhonas, John S, Dana, Sharon L, Bilakovics, James M, Paterniti, Jr., James R, Ogilvie, Kathleen M, Liu, Sha, Kauffman, Raymond F
Format: Artikel
Sprache:eng
Schlagworte:
Adipose tissue
Adipose tissues
Analysis
Body weight
Cardiovascular diseases
Food consumption
Genetic aspects
Glucose tolerance test
Glucose tolerance tests
Liver
Measurement
Metabolism
Physiological aspects
Risk factors
Type 2 diabetes
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0012-1797